Rockefeller Capital Management
NTGN

Rockefeller Capital Management’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Rockefeller Capital Management’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,000
Closed -$3K – 2761
2020
Q1 		$3K Hold
1,000
– – ﹤0.01% 2137
2019
Q4 		$1K Hold
1,000
– – ﹤0.01% 2026
2019
Q3 		$2K Buy
+1,000
New +$3.04K ﹤0.01% 1820

Rockefeller Capital Management's NTGN Position: Q2 2020 in Review

Rockefeller Capital Management sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 1,000 shares — an estimated $3K sold.

Rockefeller Capital Management first reported a position in NTGN in Q3 2019 and held it in 3 quarters. The position peaked at $3K in Q1 2020. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

  • Rockefeller Capital Management reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Rockefeller Capital Management sold 1,000 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $3K.
  • Rockefeller Capital Management first reported a position in Neon Therapeutics, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
  • Rockefeller Capital Management's Neon Therapeutics, Inc. Common Stock position peaked at $3K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Rockefeller Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.